Mepivacaine vs. Bupivacaine Spinal Anesthetic in Total Knee Arthroplasty

Completed · Phase 4

Conditions studied: Anesthesia, Spinal, Arthroplasty, Replacement, Knee, Pain Management, Early Ambulation, Ambulatory Surgical Procedures

In brief

The purpose of this study is to determine if a shorter-acting spinal anesthetic called mepivacaine has advantages over a longer-acting medication called bupivacaine.

Key facts

Study ID

NCT02980926

Run by

Henry Ford Health System

People needed

32

Starts

2016-12-01

Expected to finish

2017-03-01

Last updated by the study team

2017-03-27

Who can join

Age: 40 and older, up to 90. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adult patients undergoing primary total knee arthroplasty

You may not qualify if…

• Chronic opioid users
• Unable to give informed consent
• Forego the use of a foley catheter
• Those with hypersensitively to amide local anesthetics or opioids
• Those with contraindications to spinal anesthesia
• Conversion to general anesthesia will be excluded.

Where it is running

• Henry Ford West Bloomfield — West Bloomfield, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.